天士力：2025年半年度归属于上市公司股东的净利润同比增长16.97%

Core Insights - Tianjin Tasly Pharmaceutical announced its financial results for the first half of 2025, reporting a revenue of 4,288,208,856.32 yuan, which represents a year-on-year decrease of 1.91% [1] - The net profit attributable to shareholders of the listed company was 774,696,532.98 yuan, showing a year-on-year increase of 16.97% [1] Financial Performance - Revenue for the first half of 2025: 4.29 billion yuan, down 1.91% year-on-year [1] - Net profit for the first half of 2025: 0.77 billion yuan, up 16.97% year-on-year [1]